As the loss of muscle mass and development of insulin resistance (i.e. impaired insulin‐stimulated glucose uptake) negatively affect our healthspan, there is ongoing focus on designing effective interventional strategies to preserve muscle mass and metabolic health in catabolic situations. The gene discussed is INS; the disease is Insulin resistance.